![]() Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ![]() HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. | |||
Founding Date | Founding Date 2008 | Founding Date 2000 | Founding Date 2010 | Founding Date 2004 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Gothenburg, SE HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Los Angeles, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more |
Employees | Employees 5 | Employees 82517% decrease | Employees 27214% decrease | Employees 1113% increase |
Valuation ($) | Valuation ($) 57.2 m | Valuation ($) 648.3 m | Valuation ($) 136.8 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $170.2m (FY, 2025) | Gross profit N/A |
Net income | Net income (kr54.2m) (FY, 2025) | Net income €162.2m (FY, 2024) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.1b | Total funding raised $ 172m | Total funding raised $ 12.6m |

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View company